BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10078986)

  • 1. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
    Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
    Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation.
    Tomiyama K; McNamara FN; Clifford JJ; Kinsella A; Koshikawa N; Waddington JL
    Eur J Pharmacol; 2001 Apr; 418(1-2):47-54. PubMed ID: 11334864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J; Bøgesø KP; Hyttel J; Meier E
    Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell.
    Cools AR; Miwa Y; Koshikawa N
    Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
    Fujita S; Kiguchi M; Kobayashi M; Kinsella A; Koshikawa N; Waddington JL
    Eur J Pharmacol; 2010 Apr; 632(1-3):39-44. PubMed ID: 20122923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
    Clifford JJ; Tighe O; Croke DT; Kinsella A; Sibley DR; Drago J; Waddington JL
    Neuroscience; 1999; 93(4):1483-9. PubMed ID: 10501473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell.
    Uchida T; Adachi K; Fujita S; Lee J; Gionhaku N; Cools AR; Koshikawa N
    Eur J Pharmacol; 2005 Mar; 510(1-2):39-47. PubMed ID: 15740723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.